Sonorous Neurovascular's BosSTENT™ Gains FDA Breakthrough Device Designation to Treat Pulsatile Tinnitus Sonorous Neurovascular's innovative BosSTENT™ receives FDA Breakthrough Device Designation, offering hope for treating pulsatile tinnitus effectively.

Sonorous Neurovascular's BosSTENT™ Gains FDA Breakthrough Device Designation to Treat Pulsatile Tinnitus #USA #Lake_Forest #Sonorous_Neurovascular #BosSTENT™ #Pulsatile_Tinnitus